Wockhardt Limited (NSE:WOCKPHARMA)
India
· Delayed Price · Currency is INR 1,546.60
+36.60 (2.42%)
Jun 10, 2025, 3:30 PM IST
Wockhardt Employees
Wockhardt had 2,386 employees as of March 31, 2024. The number of employees decreased by 354 or -12.92% compared to the previous year.
Employees
2,386
Change (1Y)
-354
Growth (1Y)
-12.92%
Revenue / Employee
12.62M INR
Profits / Employee
-196.98K INR
Market Cap
251.30B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 9,741 |
| Cipla | 27,764 |
| Apollo Hospitals Enterprise | 83,147 |
| Mankind Pharma | 19,540 |
| Zydus Lifesciences | 26,921 |
| Aurobindo Pharma | 26,015 |
| Alkem Laboratories | 17,432 |
Wockhardt News
- 21 days ago - Senores Pharmaceuticals acquires USFDA-approved ANDA for Enalapril Maleate Tablets from Wockhardt - Business Upturn
- 5 weeks ago - Senores Pharmaceuticals share price jumps 3% after company acquires ANDA for Topiramate tablets from Wockhardt - Business Upturn
- 5 weeks ago - Senores Pharmaceuticals acquires ANDA for Topiramate tablets from Wockhardt - Business Upturn
- 2 months ago - Wockhardt shares climb 3% as breakthrough antibiotic Zaynich™ saves US cancer patient with drug-resistant infection - Business Upturn
- 2 months ago - Wockhardt’s novel antibiotic Zaynich™ helps save US child cancer patient battling superbug infection - Business Upturn
- 4 months ago - Wockhardt reports Q3 Results: Revenue up 3% to Rs 721 crore, Net profit at Rs 20 crore vs loss of Rs 86 crore YoY - Business Upturn
- 4 months ago - Wockhardt shares surge 10% as flagship antibiotic Zaynich demonstrates breakthrough clinical success - Business Upturn
- 4 months ago - Wockhardt’s Zaynich achieves 96.8% clinical cure rate, sets new benchmark in Phase III global study - Business Upturn